OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases
Daniel Ward, Nynne Nyboe Andersen, Sanne Gørtz, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 135-143.e8
Open Access | Times Cited: 13
Daniel Ward, Nynne Nyboe Andersen, Sanne Gørtz, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 1, pp. 135-143.e8
Open Access | Times Cited: 13
Showing 13 citing articles:
Gut microbiota does not play a mediating role in the causal association between inflammatory bowel disease and several its associated extraintestinal manifestations: a Mendelian randomization study
Weipeng Lu, JiePeng Cen, Qijie Dai, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Weipeng Lu, JiePeng Cen, Qijie Dai, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 7
Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease
Karma Yeshi, Tenzin Jamtsho, Phurpa Wangchuk
Molecules (2024) Vol. 29, Iss. 16, pp. 3954-3954
Open Access | Times Cited: 5
Karma Yeshi, Tenzin Jamtsho, Phurpa Wangchuk
Molecules (2024) Vol. 29, Iss. 16, pp. 3954-3954
Open Access | Times Cited: 5
Biological characteristics, immune infiltration and drug prediction of PANoptosis related genes and possible regulatory mechanisms in inflammatory bowel disease
Minglin Zhang, Tong Liu, Lijun Luo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Minglin Zhang, Tong Liu, Lijun Luo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Blood transcriptomics identifies FEZ1 as a potential biomarker for inflammatory bowel disease
Arman Mokaram Doust Delkhah
Computers in Biology and Medicine (2025) Vol. 187, pp. 109742-109742
Closed Access
Arman Mokaram Doust Delkhah
Computers in Biology and Medicine (2025) Vol. 187, pp. 109742-109742
Closed Access
Identification of novel indolinone derivatives as CTSC inhibitors to treat inflammatory bowel disease by modulating inflammatory factors
Xing Chen, Yan Lou, Feilong Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116914-116914
Closed Access | Times Cited: 1
Xing Chen, Yan Lou, Feilong Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116914-116914
Closed Access | Times Cited: 1
Biologika: paradoxe Krankheitsreaktion häufiger als gedacht
Susanne Krome
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 06, pp. 900-901
Closed Access
Susanne Krome
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 06, pp. 900-901
Closed Access
Blood transcriptomics identifies FEZ1 as a novel non-invasive diagnostic biomarker for inflammatory bowel disease
Arman Mokaram Doust Delkhah
(2024)
Closed Access
Arman Mokaram Doust Delkhah
(2024)
Closed Access
Psoriasis and inflammatory bowel disease: concomitant IMID or paradoxical therapeutic effect? A scoping review on anti-IL-12/23 and anti-IL-23 antibodies
Cristina Bezzio, Carolina Aliai Micol Cavalli, Gianluca Franchellucci, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Cristina Bezzio, Carolina Aliai Micol Cavalli, Gianluca Franchellucci, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access
Epidemiologic Associations Between Inflammatory Bowel Disease and Hodgkin Lymphoma or Multiple Sclerosis
Amnon Sonnenberg, Ruth Kohen
Gastro Hep Advances (2024) Vol. 3, Iss. 5, pp. 605-611
Open Access
Amnon Sonnenberg, Ruth Kohen
Gastro Hep Advances (2024) Vol. 3, Iss. 5, pp. 605-611
Open Access
Insights into New-onset Arthritis in Patients with Hidradenitis Suppurativa
Patricia Garbayo‐Salmons, Mireia Moreno, Vicente Exposito-Serrano, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40145-adv40145
Open Access
Patricia Garbayo‐Salmons, Mireia Moreno, Vicente Exposito-Serrano, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv40145-adv40145
Open Access
Improved high‐performance liquid chromatography tandem mass spectrometry method for quantification of infliximab in pediatric plasma and its application in therapeutic drug monitoring
Boran Yu, Siyao Jin, Jiaqi Han, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 18
Closed Access
Boran Yu, Siyao Jin, Jiaqi Han, et al.
Rapid Communications in Mass Spectrometry (2024) Vol. 38, Iss. 18
Closed Access
Risk of Paradoxical Rheumatoid Arthritis in Inflammatory Bowel Disease Patients Exposed to Tumor Necrosis Factor Inhibitors: A Propensity-Matched Multicenter Study
Akash Keluth Chavan, Pankhuri Jha, Jaime A. Perez, et al.
Inflammatory Bowel Diseases (2024)
Closed Access
Akash Keluth Chavan, Pankhuri Jha, Jaime A. Perez, et al.
Inflammatory Bowel Diseases (2024)
Closed Access
Is therapeutic drug monitoring a dancing partner for TNF-α inhibitors in real-world practice? Answers from an updated systematic review and meta-analysis
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
Yang Hu, Zaiwei Song, Yuan Gao, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 10, pp. 935-948
Open Access
